AVE 0.00% 0.3¢ avecho biotechnology limited

oxy update out - stay tuned, page-2

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Categorically state that all crystallisation issues are resolved. Multi-dose trials to commence eraly January and expected tot ake 6 weeks after which application for Phase 3 trials will be made. Expansion of opiod patch development to Oxymorphone, 3.5 times more potent than Oxycodene and worht over $1bill at the mment.

    Very positive announcement and confirmed what some have been saying, that commercialisation of Oxy is pushing ahead.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $3.607K 1.445M

Buyers (Bids)

No. Vol. Price($)
59 102396408 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 21041400 12
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.